News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
71,909 Results
Type
Article (5192)
Company Profile (41)
Press Release (66676)
Section
Business (18776)
Career Advice (209)
Deals (3308)
Drug Delivery (19)
Drug Development (6756)
Employer Resources (36)
FDA (974)
Job Trends (1333)
News (29444)
Policy (2315)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
Academia (288)
Allergies (10)
Alliances (4622)
ALS (5)
Alzheimer's disease (164)
Antibody-drug conjugate (ADC) (19)
Approvals (969)
Artificial intelligence (19)
Autoimmune disease (3)
Automation (1)
Bankruptcy (29)
Best Places to Work (947)
BIOSECURE Act (6)
Biosimilars (27)
Biotechnology (30)
Bladder cancer (10)
Brain cancer (8)
Breast cancer (30)
Cancer (230)
Cardiovascular disease (28)
Career advice (175)
Career pathing (3)
CAR-T (17)
Cell therapy (57)
Cervical cancer (4)
Clinical research (5238)
Collaboration (124)
Compensation (52)
Complete response letters (2)
COVID-19 (391)
CRISPR (8)
C-suite (33)
Cystic fibrosis (10)
Data (206)
Denatured (3)
Depression (5)
Diabetes (30)
Diagnostics (753)
Digital health (3)
Diversity, equity & inclusion (8)
Drug discovery (25)
Drug pricing (18)
Drug shortages (2)
Duchenne muscular dystrophy (27)
Earnings (6346)
Editorial (6)
Employer branding (6)
Employer resources (29)
Events (7913)
Executive appointments (97)
FDA (1069)
Featured Employer (5)
Funding (113)
Gene editing (17)
Gene therapy (40)
GLP-1 (113)
Government (476)
Grass and pollen (1)
Guidances (2)
Healthcare (1516)
Huntington's disease (4)
IgA nephropathy (3)
Immunology and inflammation (21)
Indications (3)
Infectious disease (412)
Inflammatory bowel disease (18)
Inflation Reduction Act (7)
Influenza (9)
Intellectual property (11)
Interviews (27)
IPO (1428)
IRA (10)
Job creations (412)
Job search strategy (155)
Kidney cancer (4)
Labor market (8)
Layoffs (52)
Leadership (2)
Legal (422)
Liver cancer (13)
Lung cancer (25)
Lymphoma (7)
Management (10)
Manufacturing (37)
MASH (11)
Medical device (715)
Medtech (715)
Mergers & acquisitions (1986)
Metabolic disorders (92)
Multiple sclerosis (7)
NASH (4)
Neurodegenerative disease (11)
Neuropsychiatric disorders (3)
Neuroscience (221)
NextGen: Class of 2025 (660)
Non-profit (420)
Northern California (439)
Now hiring (4)
Obesity (42)
Opinion (56)
Ovarian cancer (12)
Pain (10)
Pancreatic cancer (7)
Parkinson's disease (8)
Partnered (2)
Patents (24)
Patient recruitment (9)
Peanut (4)
People (6595)
Pharmaceutical (6)
Pharmacy benefit managers (7)
Phase I (1965)
Phase II (2458)
Phase III (1609)
Pipeline (115)
Podcasts (4)
Policy (26)
Postmarket research (111)
Preclinical (800)
Press Release (4)
Prostate cancer (13)
Psychedelics (2)
Radiopharmaceuticals (20)
Rare diseases (43)
Real estate (597)
Recruiting (17)
Regulatory (1618)
Reports (15)
Research institute (277)
Resumes & cover letters (34)
RNA editing (1)
RSV (2)
Schizophrenia (14)
Series A (26)
Series B (9)
Service/supplier (2)
Sickle cell disease (8)
Southern California (405)
Special edition (3)
Spinal muscular atrophy (6)
Sponsored (2)
Startups (574)
Stomach cancer (1)
Supply chain (8)
Tariffs (1)
The Weekly (1)
United States (2418)
Vaccines (97)
Venture capitalists (11)
Webinars (2)
Weight loss (32)
Women's health (2)
Worklife (2)
Date
Today (9)
Last 7 days (90)
Last 30 days (345)
Last 365 days (4308)
2025 (1118)
2024 (4252)
2023 (4482)
2022 (11208)
2021 (10427)
2020 (7681)
2019 (4190)
2018 (3175)
2017 (2686)
2016 (2512)
2015 (2739)
2014 (2035)
2013 (1770)
2012 (2030)
2011 (2020)
2010 (1722)
Location
Africa (97)
Alabama (2)
Arizona (15)
Asia (3308)
Australia (496)
California (961)
Canada (206)
China (59)
Colorado (27)
Connecticut (20)
Delaware (7)
Europe (7661)
Florida (73)
Georgia (11)
Idaho (3)
Illinois (38)
India (2)
Indiana (38)
Iowa (2)
Japan (13)
Kansas (13)
Louisiana (3)
Maine (3)
Maryland (45)
Massachusetts (453)
Michigan (17)
Minnesota (29)
Mississippi (1)
Missouri (6)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (149)
New Mexico (2)
New York (129)
North Carolina (108)
Northern California (439)
Ohio (28)
Oklahoma (2)
Oregon (4)
Pennsylvania (81)
Rhode Island (3)
South America (97)
South Carolina (2)
Southern California (405)
Tennessee (10)
Texas (104)
Utah (6)
Virginia (7)
Washington D.C. (9)
Washington State (65)
Wisconsin (6)
71,909 Results for "rising biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
GLP-1
GLP-1 Drug Boom Recalls the Rise of PD-1 Checkpoint Inhibitors
The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences suggest history may not repeat itself.
March 19, 2025
·
8 min read
·
Ben Hargreaves
Biosimilars
Humira Biosimilars Gain Ground as Doctors Adjust and New Therapies Rise
AbbVie’s Humira was the top-selling drug in the world for many years. Now, its sales are eroding as doctors switch to biosimilars and new options enter the market.
March 26, 2025
·
6 min read
·
Annalee Armstrong
Press Releases
Precision Medicine Surge: KFSHRC Achieves 39% Rise in Genetic Mutation Analysis
March 20, 2025
·
2 min read
Press Releases
RISE Robotics to be Awarded GUINNESS WORLD RECORDS™ title for Strongest Robotic Arm Prototype
March 13, 2025
·
1 min read
China
The Rise of China Innovation in the Time of Trump
With incoming president Donald Trump threatening a trade war with China, experts told
BioSpace
that the new administration will likely understand why medicines should be treated differently.
January 16, 2025
·
4 min read
·
Annalee Armstrong
Press Releases
Vizient Forecasts a 3.84% Rise in Pharmacy Spending
January 28, 2025
·
5 min read
Layoffs
IGM Biosciences Lays Off 73% of Staff, Shrinks Pipeline
Staff cuts will leave IGM Biosciences with 37 employees. The company is also halting development of two bispecific antibody T cell engagers for autoimmune diseases.
January 10, 2025
·
1 min read
·
Angela Gabriel
Infectious disease
AbbVie Gets FDA Approval for New Antibiotic in the Face of Rising Resistance
The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in partnership with Pfizer. AbbVie acquired its share of the asset as part of its $63 billion buyout of Allergan.
February 10, 2025
·
2 min read
·
Dan Samorodnitsky
Collaboration
Cassava’s Stock Rises After Licensing Seizure Rights for Embattled Drug Simufilam
The licensing deal follows years of controversy for Cassava, as well as the high-profile late-stage failure of its Alzheimer’s disease drug simufilam.
February 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Keymed Biosciences Announces Annual Results of 2024
March 27, 2025
·
12 min read
1 of 7,191
Next
